Small molecules as activators in medicinal chemistry (2000-2016)
- PMID: 28673105
- DOI: 10.1080/13543776.2017.1349103
Small molecules as activators in medicinal chemistry (2000-2016)
Abstract
From therapeutic point of view, it is often beneficial to enhance the expression of certain enzymes whose low expression is responsible for the observed ailment. Small molecules as activators of several enzymes have great biological potential as anti-microbial and anti-cancer agents, for the treatment of diabetes, obesity, metabolic disorders, and for the treatment of neurological disorders including Alzheimer's disease. This review covers patents describing small molecules as activators, and provides structural leads for the design of even more potent activators. Area covered: This review is focused on small molecules that have been explored as activators of enzymes in the last and current decade (2000-2016). Expert opinion: The ability to modulate activity of enzymes has long been a quest of medicinal chemistry. This has been the impetus behind the development of a plethora of drugs as enzyme inhibitors. However only a few enzyme activators as drugs have made it to the market. Disorders characterized by supressed enzyme activity can be treated by enhancing the activity of a specific enzyme.
Keywords: Alzheimer’s disease; Small molecules; activators; bacterial infections; cancer; enzymes.
Similar articles
-
Sirtuin modulators: an updated patent review (2012 - 2014).Expert Opin Ther Pat. 2015 Jan;25(1):5-15. doi: 10.1517/13543776.2014.982532. Epub 2014 Nov 29. Expert Opin Ther Pat. 2015. PMID: 25435179 Review.
-
Advances and strategies in NADPH oxidase inhibitors and activators patents.Pharm Pat Anal. 2014 Jul;3(4):387-409. doi: 10.4155/ppa.14.31. Pharm Pat Anal. 2014. PMID: 25291313 Review.
-
A patent review of sirtuin activators: an update.Expert Opin Ther Pat. 2012 Apr;22(4):355-67. doi: 10.1517/13543776.2012.669374. Epub 2012 Mar 9. Expert Opin Ther Pat. 2012. PMID: 22475539 Review.
-
Benzisoxazole analogs as glycogen synthase activators, a patent evaluation (WO2011057956).Expert Opin Ther Pat. 2012 Jun;22(6):701-7. doi: 10.1517/13543776.2012.681303. Epub 2012 Apr 20. Expert Opin Ther Pat. 2012. PMID: 22519818
-
Metalloenzyme inhibitors for the treatment of Gram-negative bacterial infections: a patent review (2009-2012).Expert Opin Ther Pat. 2013 Jul;23(7):777-88. doi: 10.1517/13543776.2013.777042. Epub 2013 Mar 4. Expert Opin Ther Pat. 2013. PMID: 23458841 Review.
Cited by
-
Discovery of small-molecule enzyme activators by activity-based protein profiling.Nat Chem Biol. 2020 Sep;16(9):997-1005. doi: 10.1038/s41589-020-0555-4. Epub 2020 Jun 8. Nat Chem Biol. 2020. PMID: 32514184 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources